(19)
(11) EP 1 226 270 A2

(12)

(88) Date of publication A3:
23.05.2002

(43) Date of publication:
31.07.2002 Bulletin 2002/31

(21) Application number: 00927464.8

(22) Date of filing: 28.04.2000
(51) International Patent Classification (IPC)7C12Q 1/68, C12Q 1/70, C12N 15/85, C12N 15/86
(86) International application number:
PCT/GB0001/639
(87) International publication number:
WO 0066/774 (09.11.2000 Gazette 2000/45)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.04.1999 GB 9909793

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • BLAIR, Edward Duncan,Glaxo Wellcome plc
    Stevenage,Hertfordshire SG1 2NY (GB)
  • ROBINSON, Laurence Henry,Glaxo Wellcome plc
    Stevenage,Herfordshire SG1 2NY (GB)
  • SNOWDEN, Barbara Wendy,Glaxo Wellcome plc
    Stevenage,Hertfordshire SG1 2NY (GB)
  • TISDALE, Sylvia Margaret,Glaxo Wellcome plc
    Stevenage,Hertfordshire SG1 2NY (GB)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) IMPROVED ASSAY AND REAGENTS THEREFOR